Prescription Drug Information
Download
1 / 22

Prescription Drug Information for Consumers and Healthcare Professionals 48 th FDLI Annual Meeting Washington, DC - PowerPoint PPT Presentation


  • 263 Views
  • Uploaded on

Prescription Drug Information for Consumers and Healthcare Professionals 48 th FDLI Annual Meeting Washington, DC. Wm. Ray Bullman Executive Vice President National Council on Patient Information and Education Bethesda, MD . Today’s Session.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Prescription Drug Information for Consumers and Healthcare Professionals 48 th FDLI Annual Meeting Washington, DC' - erika


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Slide1 l.jpg

Prescription Drug Information for Consumers and Healthcare Professionals48th FDLI Annual MeetingWashington, DC

Wm. Ray Bullman

Executive Vice President

National Council on Patient

Information and Education

Bethesda, MD


Today s session l.jpg
Today’s Session

  • Rx info. for consumers & healthcare providers:

    • Focus on written; 3rd party, govt., industry)

    • Variety, intended uses

    • What’s new? (development & delivery of Rx info)

      Q:Can Rx information from diverse sectors for diverse

      purposes work synergistically? (if not-why not; consequences?....)

      Maximize potential of Rx info. to support safe & appropriate medicine use

NCPIE CMI Initiative - FDLI Annual Meeting


Today s batting order l.jpg
Today’s Batting Order

 Bullman – 3rd party Rx info. 1996-2006 chronology; Consumer Medicine Information (CMI) initiative

 Seligman – government & Rx info; MedGuides, PPIs, Drug Watch, HP 2010, assessing CMI

 Goldhammer – Industry & Rx Info; Paperless Labeling Initiative

 Winckler – Nexus: Rx Info & the pharmacist

NCPIE CMI Initiative - FDLI Annual Meeting


Precursor proposed medguide rule l.jpg
Precursor: Proposed MedGuide Rule

  • August 24, 1995, Federal Register: proposed FDA rules would institute a manufacturer-prepared, FDA-approved Rx info. system --”medication guides" -- to accompany all prescriptions.

NCPIE CMI Initiative - FDLI Annual Meeting


Proposed medguide rule l.jpg
Proposed MedGuide Rule

  • Outlined two regulatory alternatives: Plans A and B.

  • Under A, voluntary system given opportunity to achieve specific goals; if goals not met, regulations requiring Medication Guides would be implemented.

  • Under B, matters proceed as in A but, FDA does not intend to finalize proposed standards or the sections that defer implementation in the form of regulation. Instead, the agency intends to use the proposed performance standards as guidance for the private sector.

NCPIE CMI Initiative - FDLI Annual Meeting


Proposed medguide rule leads to action plan for useful rx info l.jpg
Proposed MedGuide Rule Leads to Action Plan for Useful Rx Info.

  • Public Law 104-180 signed 08/29/96

  • Directs HHS Secretary to facilitate development of long-range Action Plan

  • Codifies FDA’s ‘95 proposed Medication Guide distribution and quality goals of 75% by 2000 and 95% by 2006.

NCPIE CMI Initiative - FDLI Annual Meeting


Action plan development l.jpg
Action Plan Development

  • HHS Secretary contracts with Keystone Center, a nonprofit dispute resolution center

  • 120 days under statute (PL 104-180) to facilitate development of Action Plan by interested stakeholders

  • Keystone selected 34 private sector groups to develop Action Pan

NCPIE CMI Initiative - FDLI Annual Meeting


Action plan for provision of useful prescription medicine information l.jpg
Action Plan for Provision of Useful Prescription Medicine Information

Collaboratively developed Action Plan accepted

by the Secretary in January 1997; (no consensus on implementation mechanism)

Criteria to determine usefulness:

* endorsed broad criteria in the public law

* described 8 specific criteria to be met; recommended layout /design attributes

(see last four slides)

Consistent with PL 104-180, Action Plan called for periodic assessment of quality of written Rx information.

NCPIE CMI Initiative - FDLI Annual Meeting


1998 fda final medguide rule l.jpg
1998 - FDA Final MedGuide Rule Information

  • Rule estimates 5-10 products per year could have Medication Guide

  • MedGuide reserved for drugs with serious and significant side effects, etc.

  • To date (4/07) FDA has required MedGuides for ___Rx drugs & biologics (most recent = SSRIs, Elidel, Protopic, NSAIDs…… )

NCPIE CMI Initiative - FDLI Annual Meeting


Fda assesses cmi 2002 l.jpg
FDA Assesses CMI Information(2002)

  • Dr. Bonnie Svarstad (Univ. WI – Madison) hired by FDA to assess interim progress towards meeting Action Plan quantity & quality standards.

  • 384 pharmacies randomly selected from virtually every state; shopping service buys 4 Rx drugs and collects CMI.

NCPIE CMI Initiative - FDLI Annual Meeting


Fda interim assessment of cmi 2002 l.jpg
FDA Interim Assessment of CMI Information(2002)

  • Distribution of CMI @ 89% (target = 75%)

  • Usefulness of CMI variable

    50% - 55% criteria met (target =75%)

  • Best performance:

    • Scientific accuracy, non-promotional

    • Pregnancy contraindication

NCPIE CMI Initiative - FDLI Annual Meeting


Fda interim assessment of cmi 200212 l.jpg
FDA Interim Assessment of CMI Information(2002)

  • Completeness of CMI is POOR and Variable

    Worst: Communication & Risk Information

    • Contraindication and what to do

    • Precautions and how to avoid harm

    • Readability

      Poor: Communicating how to get most benefit

    • ADRs and what to do

    • Directions for use and monitoring

    • Encouragement and ask questions

NCPIE CMI Initiative - FDLI Annual Meeting


Consumer medicine information cmi initiative l.jpg
Consumer Medicine InformationInformation (CMI) Initiative

  • NCPIE, in 2003,convenes stakeholders interested in collaborating to meet Action Plan goals by

    Dec. 2006:

    • the distribution of useful information to 95% of individuals receiving new prescriptions;

    • Useful defined relative to Action Plan as assessed by FDA in 2007

NCPIE CMI Initiative - FDLI Annual Meeting


Cmi stakeholders l.jpg
CMI Stakeholders Information

  • Drug information publishers - First DataBank, Medi-Span, Micromedex, Catalina Health, Etreby, Cerner Multum

  • Pharmacy system vendors -ASAP & members

  • Pharmacy/pharmacists – APhA, ASHP, NACDS, NCPA, NABP

  • Consumer & patient advocacy orgs – AARP, NCL

  • PhRMA & several individual companies

  • Others – AMA, VA

NCPIE CMI Initiative - FDLI Annual Meeting


Recent cmi initiative activities l.jpg
Recent CMI Initiative Activities Information

  • A Guide for Determining the Usefulness of Consumer Medicine Information (CMI) – 2004; (distribution pending review of FDA draft guidance document on CMI)

  • Stakeholders’ meetings w/ FDA (03/03, 03/04, 06/04)

    Next stakeholders’ meeting will follow release of draft

    guidance document on CMI by FDA 

  • Numerous CMI articles & presentations.

NCPIE CMI Initiative - FDLI Annual Meeting


Cmi initiative how you can help l.jpg

Support / participate in future CMI stakeholders’ meetings

.

Support dissemination of “Guide for Determining Usefulness of CMI”

Support pharmacy / vendor efforts to integrate CMI prototypes into pharmacy systems

Support research on value / use / impact of CMI; reaction to AP-compliant CMI prototypes

Support CMI public awareness (its function, capacity to inform; optimizing use of CMI)

CMI Initiative: How You Can Help

NCPIE CMI Initiative - FDLI Annual Meeting


Web link l.jpg
Web Link

For details about CMI Initiative:

www.talkaboutrx.org

You’ll find background on CMI Initiative and

links to:

* Public Law 104-180

* Action Plan for Provision of UsefulPrescription Medicine Information

* FDA interim CMI assessment

* Early CMI prototypes

NCPIE CMI Initiative - FDLI Annual Meeting


Cmi initiative contact l.jpg

CMI Initiative Contact

Ray Bullman

Executive Vice President

National Council on

Patient Information and Education

4915 Saint Elmo Ave., #505

Bethesda, MD 20814 - 6082

(301) 656-8565, ext. 14

[email protected]

www.talkaboutrx.org


Cmi action plan eight criteria for useful medicine information l.jpg
CMI Action Plan -- Eight Criteria for Useful Medicine Information

  • Drug Names and indications

    2. Contraindications and what to do before using

    3. Specific directions about how to use, monitor, get most benefit

    4. Specific precautions & how to avoid harm

NCPIE CMI Initiative - FDLI Annual Meeting


Cmi action plan eight criteria for useful medicine information20 l.jpg
CMI Action Plan -- Eight Criteria for Useful Medicine Information

  • Serious/frequent adverse reactions, what to do

  • General information, encouragement to ask questions

    7. Scientifically accurate, unbiased & up-to-date

    8. Comprehensible (6-8th grade) & legible

NCPIE CMI Initiative - FDLI Annual Meeting


Comprehensibility items l.jpg
Comprehensibility Items

  • Poorly – well organized

  • Poor – good length

  • Unclear – clear

  • Unhelpful – helpful

  • Incomplete – complete

  • Hard – easy to find impt. information

NCPIE CMI Initiative - FDLI Annual Meeting


Legibility and summary items l.jpg
Legibility and Summary Items

  • Legibility: Poor – good

    - print size;

    - print quality;

    - spacing between lines

  • Summary Items: overall ease of reading, overall ease of understanding, overall usefulness

NCPIE CMI Initiative - FDLI Annual Meeting


ad